Various extracts of the aerial parts of Coleus forskohlii (Labiatae) were prepared and evaluated at their non cytotoxic concentration against HIV-1 NL4-3 . Chloroform, ethyl acetate and n-butanol extracts showed 45.6, 66.5 and 37.7% inhibition of HIV, respectively in CEM-GFP cells infected with HIV-1 NL4-3 at 5 µg/mL. Four diterpenes, 1-deoxyforskolin, 1,9-dideoxyforskolin, forskolin and isoforskolin were isolated from the chloroform extract and tested against the virus. Six semi-synthetic derivatives of forskolin have been prepared to study SAR. 1-Deoxyforskolin and forskolin were found to be active against HIV NL4-3 . This is first report of anti HIV activity of this plant and its isolated constituents.
The WHO 2008 report on the global AIDS epidemic estimated that, globally, 33 million people were living with HIV and the number of new HIV infections in 2007 was 2.7 million. In the same year, HIV infection was responsible for 2 million deaths [1] . Plant based natural products have been shown to posses promising activities that could assist in prevention and/or treatment of the disease [2] . Diterpenoid lactones, as well as phenolic and phorbol diterpenes, have been reported to exhibit anti HIV activity [3] .
We have recently embarked on a project to find anti-HIV compounds from Indian medicinal plants and selected Coleus forskohlii (Willd) Briq. [syn. C. barbatus (Andr.) Benth], family Labiatae, as it is reported to contain various diterpene lactones and labdane diterpenes. The plant is widely used as a traditional medicine and its major constituent forskolin, is reported to show various biological properties, including cardiotonic, antihypertensive, and adenylcyclase activator activities [4, 5] . Standardized extracts (10 and 20% forskolin) are marketed as a slimming agent. They have an excellent safety profile and are generally without toxicity or side effects at the recommended dosage [6] .
Preliminary investigation of various extracts of C. forskohlii revealed that the chloroform, ethyl acetate and n-butanol extracts showed 45.6, 66.5 and 37.7% inhibition of HIV-1 NL 4-3 at 5 μg/mL in CEM-GFP cells. AZT was used as a standard at a concentration of 1.28 μg/mL ( Figure 1 ). As CHCl 3 gave the highest extractive yield and the majority of the labdane diterpenes have been reported from this extract, it was investigated further and four labdane diterpenes were isolated from the extract and identified as 1-deoxyforskolin (1), 1,9-dideoxyforskolin (2), forskolin (3) and isoforskolin (4) by comparison of experimental and literature data [7] [8] [9] . All the isolated compounds were tested and compounds 1 and 3 showed high inhibition against HIV-1 NL4-3 at 5 µg/mL (Figure1). All the compounds were non-cytotoxic up to a concentration of 20 μg/mL in CEM-GFP cells.
Further, to establish structure activity relationships, various semi-synthetic derivatives (5-10) were synthesized [10] . All synthesized compounds were evaluated against HIV-1 NL4-3 at 5 µg/mL. None of the compounds was found to be active, though 7 showed moderate inhibition (22.6%) at its non-cytotoxic concentration (40 µg/mL). An analysis of the structural requirement for anti-HIV activity suggested that -OH at C-9 and -OAc at C-7, together with -OH at C-6, C=O at C-11, and a double bond at C-14 may be essential groups for activity. Removal of either -OH from C-9 (2) or -OAc from C-7 (4, 5) resulted in loss of activity. Furthermore, reduction of C=O at C-11 (8-10) and the double bond at C-14 (6) diminished the activity. Oxidation of -OH at C-1 and C-6 also reduced activity (7) . In addition to the known activity of forskolin in increasing cyclic AMP levels, these analogues may be involved in some unknown changes inside the cell, which might lead to modest inhibition of viral replication.
Observation of anti HIV-activity of C. forskohlii extracts and of compounds isolated from them indicates the potential of forskolin (3) and related compounds for generating new lead molecules from new compounds synthesized earlier for SAR studies for various properties, such as adenyl cyclase activation, positive inotropic, anti glaucoma, anti inflammatory, bronchodialatory, and antihypertensive activities [11] [12] [13] [14] [15] [16] .
Experimental
General: MS were recorded on a LCMS (LCQ, Finnigan MAT, USA) and NMR spectra on a 300 MHz spectrometer (Avance DPX 300, Bruker, Germany). Pre-coated silica gel 60 F 254 plates, 0.2 mm thickness (Merck, Germany) were used for TLC. Silica gel 60-120 mesh (CDH laboratory reagents, India) was used for column chromatography. Terpenes were detected by anisaldehyde sulfuric acid reagent.
Extraction of plant material:
Aerial parts of Coleus forskohlii were procured from the local market and identified and authenticated by Dr A. S. Sandhu, Department of Natural Products, NIPER. Plant material (1.1 kg) was extracted with methanol for 48 h using a Soxhlet extractor (Perfit India Ltd., India). The extract was concentrated using a vacuum rotary evaporator (Buchi R-200, Switzerland) to yield 133.0 g (12.1%) of dry extract. This was partitioned into n-hexane, chloroform, ethyl acetate and n-butanol fractions to yield 15.0 g (1.36%) of n-hexane, 17.3 g (1.6%) of CHCl 3 , 3.5 g (0.32%) of EtOAc and 9.1 g (0.82%) of n-BuOH extracts.
Isolation of compounds:
A portion of the chloroform extract (2.8 g) was subjected to column chromatography on silica gel using n-Hex-EtOAc in Anti HIV diterpenes from Coleus forskohlii Natural Product Communications Vol. 4 (9) 2009 1175 a gradient manner from 0 to 30% of EtOAc. Based on the TLC pattern, fractions were pooled into 6 major fractions (1 to 6). Fraction 2 (120 mg) was further chromatographed on silica gel using n-Hex-EtOAc (0-10%) to yield a mixture of 2 compounds (90 mg), which was rechromatographed on silica gel using n-Hex-CHCl 3 (0-100%) and n-Hex-EtOAc (0-3%) to yield 1 (14 mg) and 2 (16 mg). Fraction 4 (480 mg) was chromatographed on silica gel using n-Hex-EtOAc (0-20%) to yield a major fraction (330 mg), which was rechromatographed on silica gel using n-Hex-EtOAc (0-15%) to yield 3 (35 mg). Similarly, fraction 5 (360 mg) was chromatographed on silica gel using n-Hex-EtOAc (0-20%) to yield a fraction (82 mg), which was rechromatographed on silica gel using n-Hex -EtOAc (0-15%) to yield 4 (26 mg).
Anti-HIV screening in CEM-GFP cells: Human CD4+ T cell line, CEM-GFP cells were infected with
HIV-1 NL-4.3 virus at a multiplicity of infection (MOI) of 0.01 using the standard protocol [17] . The infection was monitored by GFP visualization under the microscope. The cells were then incubated with samples for up to 9 days post infection. Preliminary screening was performed by GFP quantitation by microfluorimetry. Virus production was then analyzed in the culture supernatant on day-7 post infection by p24 antigen capture ELISA.
